FMR CORP 13D/13G Filings for Kura Oncology, Inc. (KURA)

FMR CORP 13D and 13G filings for Kura Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-03-10
09:48 am
Sale		 2022-03-09 13G Kura Oncology, Inc.
KURA		 FMR CORP 241,463
0.362%		 -5,340,737decrease
(-95.67%)		 Filing
2022-01-10
1:26 pm
Sale		 2022-01-07 13G Kura Oncology, Inc.
KURA		 FMR CORP 5,582,200
8.387%		 -3,533,840decrease
(-38.77%)		 Filing
2021-02-08
10:27 am
Purchase		 2021-02-05 13G Kura Oncology, Inc.
KURA		 FMR CORP 9,116,040
13.821%		 2,318,838increase
(+34.11%)		 Filing